GV/ADVERTISING
File No. GVA-2026  ·  Regulated Health Marketing
Book a compliance review
Exhibit A — Why your ad account got restricted

Your marketing is one sentence away from a warning letter.

GV Advertising builds paid acquisition for telehealth practices, med spas and GLP-1 clinics — funnels, Meta ads and lead automation written to survive FDA, FTC and platform review before they go live, not after somebody complains.

Exhibit A · Redlined ad copy Reviewed 2026 · GV Advertising
✕ As submitted — will be flagged

Get the same active ingredient as Ozempic for 80% less. Lose 20 lbs in 30 days, guaranteed. No doctor visit required — start today.

1. Equivalence claim. FDA sent a warning letter over exactly this framing on compounded semaglutide.
2. Quantified outcome + guarantee. Unsubstantiated health claim under FTC substantiation rules.
3. Implies prescription without clinical evaluation — platform policy violation and a state telehealth problem.
✓ After redline — runs clean

A licensed provider reviews your intake and decides if treatment is appropriate. Results vary by patient. Online visit in minutes — no clinic waiting room.

Kept: the convenience angle, the price angle and the speed angle — the three things that actually drive the click.
Removed: the brand comparison, the number, the guarantee.
Result: same hook, no equivalence claim, no unsubstantiated outcome, no implied prescribing.
$7.8M
FTC settlement — BetterHelp, 2023
$1.5M
FTC penalty — GoodRx, 2023
FDA
Warning letter — Hims & Hers, Sept 2025
Statement of the problem

Generic agencies write ads that get you banned.

The playbook that works for e-commerce — bold claims, before/afters, retargeting everyone who touched the page — is the exact playbook that costs regulated health brands their ad account, their payment processor, or their certification.

01

The copy problem

Naming a brand drug, promising a number on the scale, or implying a prescription without evaluation. Every one of these is a documented enforcement trigger — and most agencies write all three in the first draft.

02

The tracking problem

Firing a standard pixel on an intake form ships health-adjacent data to an ad platform. That is the exact conduct the FTC fined BetterHelp and GoodRx for. Your funnel needs server-side events with health fields stripped, not a copy-pasted pixel.

03

The email problem

Lifecycle email for health brands has to clear CAN-SPAM, keep clinical language out of subject lines, and never expose in an inbox preview what someone is being treated for.

04

The certification problem

If you are pursuing or holding LegitScript certification, your public-facing marketing is part of the review. Ad copy written without that in mind can undo months of paperwork.

Docket — What enforcement actually looks like

Three cases every health marketer should have read.

These are public, verifiable actions against companies far better funded than yours. None of them were sloppy operators. All three got caught on marketing mechanics.

FDA
Warning letter
September 2025
Hims & Hers

The equivalence claim

FDA issued a warning letter over promotional material stating that the company's compounded semaglutide contained "the same active ingredient" as Ozempic and Wegovy — framing the agency treated as a misleading claim about an unapproved compounded drug.

Takeaway: comparing your compounded product to a brand drug is not a clever hook. It is the single most watched sentence in GLP-1 marketing.
FTC
Settlement
2023
$7.8M — BetterHelp

The pixel that shared intake answers

The FTC alleged BetterHelp shared consumers' health questionnaire responses and email addresses with Meta, Snapchat, Pinterest and others for ad targeting, after promising to keep that information private. Settlement: $7.8 million in consumer refunds.

Takeaway: your tracking setup is a compliance surface, not a technical detail. Standard pixel on an intake form is the exact fact pattern.
FTC
Civil penalty
2023
$1.5M — GoodRx

The same mistake, again

The FTC's first-ever enforcement action under the Health Breach Notification Rule: $1.5 million for sharing personal health information with advertising platforms including Meta and Google, contrary to its own privacy promises.

Takeaway: two enforcement actions in one year on the same mechanic. This is a priority area, not a one-off.
Scope of services

What I actually build.

Not strategy decks. Live assets: creative that runs, funnels that convert, tracking that does not put you in a filing.

A

Compliance-first creative

Video and static ads for Meta and TikTok, scripted and redlined against FDA and FTC claim rules and platform health policy. Every script ships with a written rationale for what was kept and what was cut.

B

Funnels & landing pages

Intake-to-consult flows built for regulated conversion: qualification before the pitch, disclosure where it belongs, and no claim on the page you cannot defend.

C

Lead automation & tracking

Server-side conversion events with health-identifying fields stripped, CRM routing, and speed-to-lead follow-up so paid traffic does not die in an inbox.

D

Lifecycle email & SMS

Nurture and reactivation sequences that clear CAN-SPAM, keep clinical detail out of preview text, and are written for people who are hesitant, not people who are ready.

Engagement terms

Three ways to work together.

Month to month after an initial 90-day term. No setup fee. Ad spend is billed directly by the platform to your account — I never touch your card, and I do not mark up media.

Section 1

Compliance Creative

For clinics with an in-house marketer or an existing agency who keep getting rejected or restricted. I handle the creative and the claim risk; you run the media.

$3,500per month
  • 1(a) 8 compliance-reviewed video ad scripts per month, with written redline rationale
  • 1(b) 4 produced video creatives per month, ready to upload
  • 1(c) 12 static / carousel variations built from the winning angles
  • 1(d) Redline review of any copy your team writes — unlimited, 48-hour turnaround
  • 1(e) Monthly creative performance readout with the next month's angle roadmap
Limited — 2 clients at a time
Section 3

Full Marketing Partner

You do not have a marketing team and do not want to build one. I own acquisition end to end and report to you like a department head.

$8,000per month
  • 3(a) Everything in Section 2
  • 3(b) Lifecycle email and SMS — nurture, reactivation, win-back sequences
  • 3(c) Multi-channel expansion: TikTok, YouTube, Google as the data justifies
  • 3(d) Full marketing compliance audit of your site, funnel and existing assets — delivered in the first 30 days
  • 3(e) Bilingual EN / ES creative and funnels at no additional cost
  • 3(f) Weekly call, shared dashboard, quarterly strategic plan

Ad spend is separate and paid by you directly to the platform. Video production is included at the volumes stated above; volume beyond that is quoted separately. Section 3 is capped at two concurrent clients so the weekly cadence stays real.

Procedure

How the first 30 days go.

Compliance review call — 30 minutes, free

You show me what is running now. I tell you, on the call, which lines would get flagged and why. You keep that list whether or not we work together.

Written scope and terms

One page: which Section, what ships, what it costs, what I need from you. No 20-page proposal, no discovery fee.

Days 1–10 — Audit and foundation

Tracking rebuilt server-side, funnel mapped, claim inventory of every asset you currently have public.

Days 11–20 — First creative batch live

Angles tested against real traffic, not a focus group. Every script comes with its redline rationale attached.

Days 21–30 — Readout and roadmap

What converted, what got flagged, what we scale next month. In writing, with the numbers.

Anticipated objections

Fair questions.

Are you a lawyer? Is this legal advice?

No, and no. I am a marketer who builds inside the constraints regulators and ad platforms have already published. I write copy that avoids known enforcement triggers and I document why. Your counsel signs off on legal questions — my job is to make sure there is far less for them to object to.

Can you guarantee my ads never get rejected?

No one honest can. Platform review is partly automated and inconsistent. What I can do is remove the categories of copy that draw enforcement attention, keep a documented rationale for every claim, and handle appeals when a clean ad gets caught anyway.

Why does compliant creative cost more than a general agency?

Because the failure mode is different. A rejected e-commerce ad costs you a day. A restricted health ad account can cost you the quarter, and an enforcement action costs more than every agency invoice you will ever pay. You are buying the review, not just the video.

Do you work with compounded GLP-1 providers?

Yes — that is the core of this practice. It is also the category where the claim rules are tightest, which is exactly why generic agencies keep getting those accounts shut down.

Do you handle Spanish-language campaigns?

Yes. Native bilingual EN / ES — creative written in Spanish, not translated from English. Included at no extra cost in Section 3.

What do you need from me to start?

Access to your ad account and analytics, whatever creative you have running, and one person who can answer clinical questions when a script needs a factual check. That is it.

Free · 30 minutes · No pitch deck
Request for review

Bring me one ad. I will tell you what is wrong with it.

Thirty minutes, no charge, no obligation. You leave with a written list of the lines in your current marketing that would draw a flag — and why. If you never hire me, you still fix those lines.

gary@gv-adv.com

Exhibit F — Published notes

Field notes